G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance. (2015)

First Author: Munir S
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dku474

PubMed Identifier: 25414202

Publication URI: http://europepmc.org/abstract/MED/25414202

Type: Journal Article/Review

Volume: 70

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 3

ISSN: 0305-7453